|
|
||||||||||||||
|
|
|||||||||||||||
ORIGINAL ARTICLE |
1 Department of Medicine, Saint Barnabas Medical Center, Livingston, NJ 07039, USA
2 Department of Pathology, Saint Barnabas Medical Center
3 Department of Pathology, Saint Barnabas Medical Center
4 Department of Pathology, Saint Barnabas Medical Center
5 Department of Medicine, Saint Barnabas Medical Center
6 Genetic Epidemiology Division, Cancer Research UK Clinical Centre in Leeds, St Jamess University Hospital, Leeds LS9 7TF, UK
Correspondence to:
Dr N P Zauber
Department of Medicine, Saint Barnabas Medical Center, Livingston, NJ 07039, USA; pzauber{at}aol.com
Aims: The primary aim of this study was to look for possible correlations between molecular genetic changes in primary colorectal cancer and the presence or absence of micrometastases in the accompanying pericolonic lymph nodes. The secondary aim was to correlate the data on these molecular genetic changes and micrometastases with survival.
Methods: One hundred and twenty five Dukess stage B colorectal cancers from 1989 to 1992 were analysed. The primary tumours were evaluated for Ki-ras mutation, adenomatous polyposis coli (APC) loss of heterozygosity (LOH), deleted in colon cancer (DCC) LOH, and microsatellite instability using standard molecular techniques. All available lymph nodes were immunohistochemically stained for micrometastases.
Results: Micrometastases were present in 41% of patients. There were significantly more lymph nodes removed in the patients with micrometastases. Micrometastases were not associated with Ki-ras mutation, APC LOH, DCC LOH, or microsatellite instability, even when controlling for the number of lymph nodes removed. None of the molecular variables considered had a significant impact on either overall survival or on death with disease.
Conclusions: There are insufficient data to justify using molecular genetic changes in primary colorectal carcinomas as prognostic markers. Micrometastases do not provide prognostic information on survival. There is value in increasing the numbers of lymph nodes removed and analysed along with the primary tumour.
Abbreviations: APC, adenomatous polyposis coli; DCC, deleted in colon cancer; H&E, haematoxylin and eosin; LOH, loss of heterozygosity; MSI, microsatellite instability; PCR, polymerase chain reaction; SSCP, single stranded conformation polymorphism
Keywords: APC gene; Dukess B colon cancer; Ki-ras gene; micrometastases
This article has been cited by other articles:
![]() |
R. R. Turner, C. Li, and C. C. Compton Newer Pathologic Assessment Techniques for Colorectal Carcinoma Clin. Cancer Res., November 15, 2007; 13(22): 6871s - 6876s. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Y. Locker, S. Hamilton, J. Harris, J. M. Jessup, N. Kemeny, J. S. Macdonald, M. R. Somerfield, D. F. Hayes, and R. C. Bast Jr ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer J. Clin. Oncol., November 20, 2006; 24(33): 5313 - 5327. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
| Journal of Clinical Pathology | Molecular Pathology |